RE:RE:RE:RE:RE:RE:AACR 2024 : Cancer vaccines get reintroduction with pathway News they know nothing about.. LOL... come on wazzak, you can do better than that.
I attend Type C meetings as part of my role... chump... So I think I'd have a clue as to timelines, and what is going on...
ONCY probably doesn't have a confirmed biomarker yet... or one assessed by FDA. Being able to separate non-responders from (potential) responders up front has always been hoped to minimise the number of patients required for recruitment (and thus trial duration). I guess they must just about have enough patient OS data, to make them think they have a shot at getting their biomarker confirmed by FDA.
BUT the outcome is an an UNKNOWN... IF ONCY was absolutely certain their biomarker would be accepted, the trial design would already be in the bag...
This isn't a done dea and it is neither negative or positive until FDA feeds back to ONCY at the end of June. If you don't think it's important to assess the potential pitfalls of an investment before you count your winnings... then maybe this explains why you're only up 2 pennies on your ONCY investment over the past year.
I'm neither negative nor positive about this news... It depends what happens in June.